1. Introduction {#s0005}
===============

The main components of cigarette smoke are nicotine, tar, carbon monoxide, nitrogen oxides, and hydrogen cyanide. Cigarette smoking is known to be a major risk factor for airway pathologies like chronic obstructive pulmonary disease and emphysema. Furthermore, it has been recognized to have a carcinogenic effect, being responsible not only for malignancies of the respiratory tract (particularly lung and larynx cancer) but also for bladder and pancreatic cancer. Moreover, it also affects the cardiovascular system as it promotes and accelerates atherosclerosis, especially in coronary arteries, aorta, carotid arteries, and arteries of the lower extremity leading to an increased risk of coronary artery disease, aneurysm enlargement, stroke, and peripheral arterial occlusive disease ([@b0100]). Several studies have demonstrated that cigarette smoking leads to an acute increase in heart rate ([@b0235], [@b0105]) and arterial blood pressure ([@b0070], [@b0190]) induced by systemic vasoconstriction ([@b0265], [@b0020]). Vasomotor dysfunction and impairment of vasodilatation are the earliest manifestations of atherosclerotic changes in a vessel ([@b0015]).

Thiocyanate anions (SCN^−^), a component of cigarette smoke, arise from the detoxification of hydrogen cyanide ([@b0225]) and these plasma SCN^−^ concentrations were found to correlate significantly with self-reported daily cigarette consumption ([@b0245]). The level of hydrogen cyanide in mainstream cigarette smoke ranges from 10 to 400 µg per cigarette in US brands ([@b0060], [@b0130]) whereas in non-filtered cigarettes the levels were between 400 and 500 µg ([@b0085]). In contrast, the amount of nicotine per cigarette ranges from 1000 to 3000 µg ([@b0085]). There is also evidence that atherosclerotic disease progression in the aorta is much more rapid when serum SCN^−^ levels are increased ([@b0210], [@b0025]). Because of the link between elevated serum SCN^−^ concentrations and atherosclerotic disease, the effect of SCN^−^ has been of particular interest ([@b0125]).

Melatonin is a tryptophan-derived, multifunctional, non-toxic indolamine that is mainly produced by the pineal gland, but also by other extrapineal organs. It is released from the pineal gland in a circadian manner resulting in low circulation levels during the day and high concentrations during the night ([@b0035]). Melatonin regulates a variety of physiological functions ([@b0175]) and has been attributed to be uncommonly effective in reducing oxidative stress ([@b0170]). One of its pleiotropic activities is the capability of scavenging not only oxygen- but also nitrogen-based reactants ([@b0110]) leading to a reduction in oxidative damage ([@b0135]). Therefore, [@b0240] entitled melatonin a potent and inducible endogenously-occurring antioxidant. Besides its antioxidative properties, melatonin also has an anti-inflammatory potential ([@b0140]). As oxidative stress and inflammation are important causative factors in atherosclerosis formation ([@b0055]), it is believed that melatonin with its atheroprotective effects may be useful either as a sole therapy or in conjunction with others ([@b0110]). In addition, melatonin is also involved in vasomotor control ([@b0075]) as it has the potential to decrease the aortic contractile responses to phenylephrine ([@b0095]). In the aorta with its elastic properties, changes in the aortic wall structure can lead to increased aortic stiffness which is known to be associated with several vascular diseases and predictive of increased cardiovascular mortality ([@b0010]). Apart from the aforementioned abilities, melatonin develops its beneficial effects also against toxic agents including nicotine ([@b0040], [@b0050]). [@b0215] reported that melatonin administration to nicotine-treated rats caused a marked reduction in the microscopic damage of the aortic tissues compared to those of the untreated group. [@b0200] described beneficial effects of melatonin in nicotine-induced vasculopathy by blocking the activation of ERK. The same group also reported about the reduction of vasoconstriction and improvement of endothelial physiology by melatonin ([@b0205]). In a recent study, the protective role of melatonin supplementation against nicotine-induced liver damage in mice has been reported ([@b0145]). The presented study was thus undertaken to quantify the thiocyanate-induced vasoconstriction in rat aortic segments and further to examine the potential of melatonin in attenuating the generated vasomotor response.,

2. Methods and materials {#s0010}
========================

2.1. Animals and preparation of vessel segments {#s0015}
-----------------------------------------------

Experiments were carried out in sixteen adult male normotensive Wistar rats grown to 200 g and approximately 6 weeks of age. These rats were housed in a room with constant temperature of 24 °C and kept under light from 08:00 to 20:00 during the day. Rats had access to food and water ad libitum. After about one week of housing they were sacrificed by decapitation, the abdominal aorta was carefully removed. Collected aortas were dissected and freed from adhering fat and surrounding connective tissue. The abdominal aortas were cut into small segments of 4 mm in lengths. Special care was taken to avoid damage of the endothelium. Material from each rat was split, to use for its own control, in order to decrease the chance that differences could be caused by investigating different animals. Investigations were designed in accordance with the guidelines of the local ethics committee.

2.2. Organ bath procedure and vasomotor responses {#s0020}
-------------------------------------------------

Each vessel segment was mounted in a temperature-controlled 15 mL tissue bath (37 °C) containing a modified Krebs--Henseleit buffer solution (118 mmol/L NaCl, 20 mmol/L NaHCO~3~, 4 mmol/L KCl, 1.25 mmol/L CaCl~2~, 1.2 mmol/L NaH~2~PO~4~, 1.2 mmol/L MgSO~4~, 4.5 mmol/L glucose, and 10 U/L insulin) as described and used previously ([@b0160], [@b0165]). The bath was continuously bubbled with a mixture of 95% O~2~ and 5% CO~2~, giving a pH of 7.40. The buffer solution was continuously renewed from a reservoir using a peristaltic pump (Ismatec REGLO Digital, IDEX Germany) at a steady-state flow of 1.5 mL/min, while excess volume was drained. To measure the isometric circular wall tension of the vessels, each segment was suspended between 2 L-shaped metal pins (0.4 mm in diameter) in a myograph, as initially described by [@b0150]. To achieve maximal active force development, the vessels were initially stretched to equalize 90% of L100 (L100 = the distance between the pins if the vessel is exposed to a passive transmural pressure of 13.3 kPa). After approximately one hour, the vessels were maximally contracted with norepinephrine at a steady-state concentration of 50 µM. Only vessel segments responding with a reproducible contraction after washout with the normal buffer solution were used for further investigation. Vessel segments were precontracted to approximately 50% of their maximum contractile capacity with norepinephrine. This contraction, induced by norepinephrine, was set arbitrarily to 100% and used as an internal standard with which the relaxant/constrictant response in the same vessel segment was compared. Maximum endothelium-dependent relaxation was regularly achieved by bolus application of 10 nmol/L of substance P directly into the organ bath in order to verify preserved endothelial responsiveness. Afterwards, the rings were exposed to SCN^−^, ranging from final concentrations in the organ bath of 10^−6^ to 10^−1^ M ([@b0080]) using a peristaltic dosing pump. To assess the effect of melatonin on vasomotor activity, organ bath concentrations were modulated from 60 to 360 pM, which corresponds to physiologic plasma up to the levels of patients with regular oral intake of melatonin as a supplement ([@b0115]). In accordance to their study, we also used 3 mg of melatonin in order to achieve an equivalent effect. Experiments were also conducted after preincubation with melatonin (360 pM) and exposure to SCN^−^ shortly thereafter. Furthermore, the effect of melatonin on aortic rings precontracted with 80 mM, as well as 160 mM, norepinephrine was investigated. Unchanged sensitivity of the smooth muscle preparations to external nitric oxide was secured by sodium nitroprusside mediated vasodilatatory response curves after use. To prevent tachyphylaxis, only one concentration-response experiment was allowed on each artery segment. All reagents were dissolved in ultra-pure water. Melatonin preparations were made freshly and restricted from ambient light. All chemicals were obtained from Sigma-Aldrich (Vienna, Austria).

2.3. Data analysis and statistics {#s0025}
---------------------------------

Vessel responses are given in millinewtons (mN) for contraction experiments, and in percentages of the maximal contraction induced by norepinephrine for relaxation experiments. Results are given as mean ± standard error of the mean (n), where n is the number of vessels, each vessel from a different animal. Statistical analysis was performed by Levene's test for equality of variances followed by an independent-sample t test for equality of means. All statistical analyses were performed using the IBM SPSS Statistic 20 software package (SPSS, Chicago, IL). P-values \<0.05 were considered statistically significant.

3. Results {#s0030}
==========

Rat aortic rings with a length of 4 mm with no evidence of macroscopic atheromatous plaque formations (n = 36) removed from twelve rats were analyzed. After being precontracted with norepinephrine, the rings revealed an endothelium-dependent vasorelaxation which was induced by administration of substance P. Subjection of these experimentally proven physiologically intact vessel segments to SCN^−^ resulted in a vasoconstriction. This effect could be markedly attenuated (56.5% reduction of effect size) in vessel segments that were preincubated with melatonin at a concentration of 360 pM. A representative original trace record is depicted in [Fig. 1](#f0005){ref-type="fig"}. In addition, SCN^−^-induced contractile reaction also showed a concentration-dependent manner. Vasoconstriction of rat aortic rings in the presence (n = 12) or absence of melatonin (n = 12) was significantly reduced (4.09 ± 1.22 mN versus 9.41 ± 1.74 mN, P \< 0.0001). Respective curves are given in [Fig. 2](#f0010){ref-type="fig"}.Fig. 1Original trace of vessel segments exposed to thiocyanate (SCN^−^) with and without preincubation of melatonin.Fig. 2Dose-dependent constriction of vessel segments exposed to thiocyanate (SCN^−^) in the presence or absence of melatonin.

Additionally, a total of twelve rings prepared out of four rat aortas were investigated to determine the vasomotor reactivity of melatonin in vessel segments precontracted with norepinephrine. At a norepinephrine concentration of 80 mM, administration of increasing concentrations of melatonin resulted in a vessel relaxation of 10.9 ± 2.2% (n = 6) when up-regulated from 60 pM to 360 pM melatonin. The vasodilatatory effect of melatonin was significantly reduced to 1.3 ± 0.5% (n = 6) when concentration of norepinephrine was doubled to 160 mM (P \< 0.002). [Fig. 3](#f0015){ref-type="fig"} illustrates respective vasorelaxation curves.Fig. 3Increasing vasodilatatory effect of melatonin in vessel segments precontracted with norepinephrine (NE) at different concentrations.

4. Discussion {#s0035}
=============

In a study performed by [@b0195] measuring SCN^−^ concentrations in office workers as a means of validating smoking histories and assessing passive exposure to cigarette smoke, a significant rise in plasma SCN^−^ corresponding with increasing smoking was obtained. All smoking groups showed mean concentrations greater than non-smokers, except those smoking five or fewer cigarettes a day. They reported SCN^−^-levels of around 40 µmol/l in non-smokers, whereas smokers consuming more than 25 cigarettes per day had concentrations approaching 160 µmol/l. In case of cessation of smoking, increased concentrations of SCN^−^ return to normal quite slowly, usually after 14 days.

Regarding the vasoreactive potential of SCN^−^, it has been reported that SCN^−^ substitution for chloride in the extracellular environment induces a contractile response in vascular smooth muscle of isolated rat aortas. After changing of the incubation medium from normal chloride-containing to a SCN^−^-modified Krebs--Ringer bicarbonate solution, resting tension increased dramatically. This effect could not be inhibited or attenuated by specific adrenergic, cholinergic, histaminergic, serotoninergic or cyclo-oxygenase inhibitors ([@b0255]). The described SCN^−^-induced contraction of vascular smooth muscle was also observed in rat portal veins ([@b0260]). However, incubation in the absence of extracellular Ca2+ abolished the SCN^−^-induced contractile responses ([@b0230], [@b0125]). [@b0045] observed similar vasoconstrictory effects of SCN^−^ in their rat tail artery perfusion model.

On the other hand, melatonin is known to serve as a modulator in a variety of cytokines and, when administered exogenously, is quickly distributed throughout the organism. Therefore, its potential clinical applicability and possible role as a disease-modulating therapeutic agent in different pathological conditions ([@b0200], [@b0200], [@b0205]) was proposed. Recently, the beneficial effects of melatonin due to its free radical scavenging capability, anti-inflammatory properties, and positive influence on the activity of antioxidative enzymes have been shown in clinical settings for several chronic diseases, such as rheumatoid arthritis ([@b0065]) and diabetes ([@b0155]). In addition, an antihypertensive and lipid normalizing effect of melatonin could be demonstrated in patients with metabolic syndrome ([@b0120]). Furthermore, it has been reported that melatonin positively influences neurobehavioral ([@b0030]) and neurochemical changes ([@b0005]) in the central nervous system. In the presented study, we elucidate that melatonin also has a functional vasoreactive effect as it significantly influences SCN^−^-induced vasomotor response in aortic rings. In detail, melatonin attenuates the vasoconstrictory effect of SCN^−^ by more than 50% when its concentration reaches plasma levels of patients with regular intake of a licensed product. The underlying biochemical pathways are already investigated and described in detail elsewhere ([@b0200], [@b0200], [@b0205]).

Being an effective antioxidant, melatonin has also proven to have a significant anti-inflammatory potential on the cardiovascular system ([@b0220]). Its beneficial effect by alleviating the inflammation as well as oxidative stress has been reported in hypoxia-induced vascular injury ([@b0090]) and nicotine-induced vasculopathy ([@b0200], [@b0200], [@b0205]). However, it is known that the production of melatonin experiences an age-related decline. In addition, [@b0185] reported that advanced age and the absence of an intact endothelium augmented the contractility response of aortic rings to vasoconstrictory substances. Therefore, elderly individuals, and especially individuals of advanced age with atherosclerotic diseases and who smoke or have a history of smoking may benefit from elevation of their reduced melatonin levels. This hypothesis is supported by data from [@b0090] who concluded that melatonin is protective against hypertension and endothelial dysfunction via an antioxidant and anti-inflammatory mechanism. In addition, recently published data suggest that melatonin could prevent the cigarette smoke-induced restenosis in rat carotid arteries after balloon injury and the mechanism of its protective effect may be the inhibition of the inflammatory reaction. This also implies melatonin has potential therapeutic applicability in the prevention of restenosis following vascular angioplasty in smokers ([@b0250]). The presented data, together with the low toxicity and high safety of melatonin, warrant further investigations in this area of vascular pathology.
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